News & Updates
Filter by Specialty:
Semaglutide lowers stroke risk in type 2 diabetes with high CV risk
A post hoc analysis of the SUSTAIN 6 and PIONEER 6 trials has found that semaglutide reduces incidence of any stroke in people with type 2 diabetes (T2D) at high cardiovascular (CV) risk vs placebo.
Semaglutide lowers stroke risk in type 2 diabetes with high CV risk
09 Sep 2022
Shift work carries higher cardiometabolic multimorbidity risk in hypertension
Hypertensive patients who work shifts face an increased risk of developing more than two cardiometabolic diseases or cardiometabolic multimorbidity, according to a study.
Shift work carries higher cardiometabolic multimorbidity risk in hypertension
08 Sep 2022
Atrial fibrillation in DM tied to end-stage renal disease
Patients with diabetes mellitus (DM) who also have atrial fibrillation (AF) are at a heightened risk of developing end-stage renal disease (ESRD), a recent study has found.
Atrial fibrillation in DM tied to end-stage renal disease
08 Sep 2022
Dietary cholesterol consumption may lead to subsequent type 2 diabetes
There appears to be a positive dose-response association between dietary cholesterol and type 2 diabetes mellitus (T2DM), where the higher the intake, the greater the incidence of T2DM especially in Western countries, according to a study.
Dietary cholesterol consumption may lead to subsequent type 2 diabetes
07 Sep 2022
Burden of microvascular disease elevates atrial fibrillation risk in T2D patients
The presence and the burden of microvascular disease in adults with type 2 diabetes (T2D) independently contribute to an increased risk of incident atrial fibrillation (AF), suggests a recent study.